Ouch! Another gene therapy setback as biotech halts 200-job Durham facility


Taysha Gene Therapies has stopped work on a planned $75 million investment in Durham.

Previous Botox studio Peachy signs lease for first NYC headquarters
Next BrewDog brings in Dutch Bros. Coffee executive as its next U.S. boss